34
Participants
Start Date
March 4, 1996
Primary Completion Date
November 1, 2014
Study Completion Date
December 10, 2014
131Iodine-Anti-B1 Radioimmunotherapy
Dosimetric dose of 450 mg unlabeled Anti-B1 followed by 35 mg Anti-B1 which has been trace labeled with 5mCi of 131I-Anti-B1.
BEAM
Carmustine (B) also known as BCNU Etoposide (E) Cytarabine (A) also known as Ara-C and cytosine arabinoside Melphalan (M) also known as alkeran
University of Nebraska Medical Center, Omaha
University of Nebraska
OTHER